Why Kendall Square?
Massachusetts plays a central role in AstraZeneca’s mission to shape the future of medicine.
With a growing presence across Kendall Square, Seaport and 100 Binney, we are bringing together cutting-edge science, world-class talent, academic partnerships and advanced technologies to accelerate breakthrough medicines for patients around the world.
- 75+ year Massachusetts legacy
- $2B Massachusetts investment
- 2,000+ colleagues across Greater Boston
- Academic and ecosystem partnerships
- Sustainable campus design
- Future growth plans across the region
One ecosystem. Multiple ways to make an impact.
Kendall Square Strategic R&D Center
Where AI, automation, biologics, cell therapy and advanced modalities come together to accelerate the next generation of medicines.
100 Binney Street
Advancing next-generation rare disease therapeutics across gene therapy, gene editing and targeted biologics.
Seaport
Home to Alexion’s Global Headquarters, connecting scientific, strategic and commercial leadership to the global rare disease mission.
Greater Boston-led innovation
Moving science further
Our teams bring together scientific expertise, advanced technologies and leading academic collaborations to help accelerate transformative medicines for patients worldwide.
Built for the future
From AI-enabled discovery to advanced therapeutics, Massachusetts is where diverse teams collaborate to help push the boundaries of what science can do.
Sustainable from the start
Our newest facilities were designed to help science and people thrive, creating environments that support wellbeing, collaboration and sustainability
Join our team in Kendall Square
Work where bold science meets global possibility.
In Kendall Square, world-class scientists, technologists and innovators come together to help shape the future of medicine.
From Oncology and BioPharmaceuticals R&D, Cell Therapy to AI and advanced modalities, you'll work alongside diverse minds transforming bold ideas into meaningful impact for patients around the world.
Explore opportunities across:
- Oncology
- BioPharmaceuticals R&D
- AI & Enterprise Technology
- Advanced Modalities
- Cell Therapy
- Biologics
Join the diverse minds helping push the boundaries of what science can do.
Apply Now
- Associate Director, Clinical AI Translation & Solutions R-261869 Cambridge, Massachusetts
- Senior Director, Testing & Quality Engineering - Evinova R-262976 Boston, Massachusetts
- Study Physician, Immunology R-261178 Cambridge, Massachusetts
- Director, Oncology Bioanalytical Strategy Lead R-260381 Cambridge, Massachusetts
- Director of AI Research, AI for Oncology Clinical Development R-262977 Cambridge, Massachusetts
- Director, AI Research R-261867 Boston, Massachusetts
- Digital Strategy Director, Oncology - Evinova R-262501 Boston, Massachusetts
- Senior Manager, RTSM Lead, Clinical Supply & External Manufacturing R-262625 Boston, Massachusetts
- Associate Scientist II, Injectable Drug Product Development R-262512 Cambridge, Massachusetts
- Director, Clinical AI Research & Evaluation R-261940 Cambridge, Massachusetts
Cell therapy is a unique modality – by engineering living cells to precisely target disease we have the potential to transform patient outcomes across multiple therapeutic areas. At AstraZeneca, we are pioneering cell therapy at scale, investing in state-of-the-art platforms, building global capabilities and pushing the boundaries of science. Our aim is to ensure many more patients can benefit from cell therapy worldwide.
Craig Maxwell-
